PHC's Pivotal Research Initiates Largest Phase I Alzheimer's Disease Trial to Date for Major National Sponsor

PEABODY, MA, Apr 10 (MARKET WIRE) --
PHC, Inc. (AMEX: PHC) d.b.a. Pioneer Behavioral Health, a leading provider of
inpatient and outpatient behavioral health services and pharmaceutical research,
reported that its Pivotal Research Centers has initiated its largest Phase I
Alzheimer's Disease trial to date for a major national sponsor.

In collaboration with four prestigious neurologists, Pivotal has begun
screening patients for the Phase I research effort, which is expected to
have major implications for the treatment of Alzheimer patients. The first
patient is expected in-house early April 2008. The Phase I activity will
continue through July 2008.

The study will involve 21 randomized patients who, under close protocol,
will
reside in Pivotal's Phase I unit for the duration of 28 days. Pivotal Research
Centers will utilize its trained and experienced Phase I staff to provide
the expertise required for the compliance and success of the trial.

Management anticipates this to be the first of many large scale, in-patient,
early-phase research studies to come. "This is the first big study since we
opened our new Phase I expanded 15-bed unit this fiscal year," said Bruce A.
Shear, Pioneer's president and CEO. "We anticipate this study to generate
approximately $750,000 over the next four months and boost profits in the
current quarter."

About Pivotal Research Centers

Pivotal Research Centers is one of the largest and most successful
clinicalresearch organizations in the nation. Having successfully completed over
600
research studies in over 45 indications, Pivotal's sites are consistently
top-enrolling in numerous studies and consistently delivers high-quality, clean
data. It has extensive experience in multiple therapeutic areas with a focus in
neurological, psychiatric, women's health,oncology and selected internal
medicine
indications. Pivotal, with it's unparalleled clinical expertise, thorough
regulatory department, state-of-the-art management processes and comprehensive
recruitmentpractices consistently deliver clean, reliable data and rapid patient
enrollment.
It's dedication and commitment to medical research has led Pivotal to be a
part of 64 medications currently FDA approved and on the market. For more
information, go to www.pivotalresearch.com.

About Pioneer Behavioral Health

Pioneer Behavioral Health operates companies that provide inpatient and
outpatient behavioral health care services, clinical research and Internet and
telephonic-based referral services. The companies contract with national
insurance companies, government payors, and major transportation and gaming
companies,
among others, to provide such services. For more information, visit
www.phc-inc.com.

Company Contact:
Bruce A. Shear
President and CEO
PHC, Inc.
Tel 978.536.2777

Investor Contact:
Liolios Group, Inc.
Scott Kitcher or Ron Both
Tel 949.574.3860
Email Contact

Copyright 2008, Market Wire, All rights reserved.

-0-